Zydus Cadila

Zydus Cadila 3-Dose Covid-19 Vaccine Approval For Children May Take Longer

A coronavirus disease (Covid-19) vaccine for children that is being developed by Gujarat-based pharmaceutical company Zydus Cadila may not be available soon as emergency approval from the country’s main drug regulator is expected. take a few more days. On July 1, the company requested authorization for emergency use of ZyCoV-D, its DNA vaccine against Covid-19 …

Zydus Cadila 3-Dose Covid-19 Vaccine Approval For Children May Take Longer Read More »

Zydus Cadila gets USFDA approval for diabetes drug

The drug company Zydus Cadila on Monday said it had received approval from the US health director to market Sitagliptin, a drug shown to treat diabetes. The company said its subsidiary had received approval from the United States Food and Drug Administration (FDA) for its new application for Sitagliptin tablets of 25, 50 and 100 …

Zydus Cadila gets USFDA approval for diabetes drug Read More »

Zydus Cadila Vaccine may be available from October

Zydus Cadila ZyCoV-D Vaccine: According to the central government, the Zydus Cadila corona vaccine may be available from the first week of October. At the same time, a decision will be taken after consulting the National Technical Advisory Group on Immunization, ie the NTAGI, on the advisability of administering it to children between 12 and …

Zydus Cadila Vaccine may be available from October Read More »

ZyCOV-D vaccine price to be revealed next week, supply begins mid-September: Group MD

ZyCOV-D vaccine price– The world’s first DNA-based vaccine for COVID-19 was approved to be administered to adults and children aged 12 years and above. It is also the second indigenous COVID vaccine in India after Covaxin. New Delhi: Sharvil Pankajbhai Patel, managing director of Cadila Healthcare Ltd, briefed on plans to roll out ZyCOV-D vaccine …

ZyCOV-D vaccine price to be revealed next week, supply begins mid-September: Group MD Read More »

Scroll to Top